DIALYSIS · CCN 292547

DaVita Spring Valley Dialysis

LAS VEGAS, NV 89103

DialysisProfitDaVita
$7.3M
TOTAL REVENUE
39.2%
OPERATING MARGIN
2 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.3M
Total costs
$4.5M
Operating income (rev − costs)
$2.9M
Operating margin
39.2%
Total charges
$7.6M
Total treatments
16,469
Dialysis stations
17

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.891—
Fistula Rate
DFC_FISTULA_RATE
54.6111—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.5346—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
150.7110—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.27——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
18111—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.1430—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
10.4114—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
23.686—
Standardized ED Visits Ratio
DFC_SEDR
1.2150—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
35.640—